Market Overview

Esperion Therapetuics Surges 13%


Shares of Esperion Therapeutics Inc (NASDAQ: ESPR) surged higher by more than 13 percent on Wednesday after the company's director, Gilbert Omenn, disclosed an insider purchase of 5,000 shares of company stock.

Omenn disclosed in a regulatory filing he bought 5,000 shares of Esperion's stock on Tuesday at a price of $15.28.

While the director's purchase isn't particularly significant in terms of size, several users on Twitter viewed the purchase as a bullish indicator.

Posted-In: biotech investors Esperion Therapeutics Gilbert Omenn Insider PurchasesNews Insider Trades


Related Articles (ESPR)

View Comments and Join the Discussion!

Eyegate Pharmaceuticals Spikes 12%; Co. Eligible To Receive Milestone Payment From Valeant

Redwood Trust Gains 2%, CEO Bought 20,000 Shares